BioSpace News Archive

IsoPlexis has received the highly coveted Red Dot Award: Product Design 2021.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (the “Company” or “Marinus”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the grant of an inducement award to Steven Pfanstiel, Marinus’ newly-hired Chief Financial Officer and Treasurer.

Forian Inc. (Nasdaq:FORA), a provider of software and technology-enabled services for the healthcare and cannabis industries, announced today that it has entered into a securities purchase agreement with a select group of institutional and accredited investors to raise gross proceeds of $12,000,000 resulting from the sale of 1,191,743 shares of its common stock at an average purchase price equal to $10.21

Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced with Eli Lilly and Company (“Lilly”, NYSE: LLY) that the results of the Phase 3 ORIENT-3 study

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, presented preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2021,

Team scores perfect quality record, initiating production facility with capacity of 60 million oral dosage form units

Diaceutics PLC, (AIM: DXRX), today announces the appointment of Yvanka Gilliam as Vice President of Operations, Asia Pacific (APAC).

Associates in Medical Physics (AMP), a recognized leader in medical physics, along with Radiation Management Associates (RMA) and Keystone Physics, has announced today the launch of a new brand identity and name - Aspekt Solutions

Caresyntax, a company dedicated to making surgery smarter and safer by delivering actionable insights with its enterprise-grade digital surgery platform, announced that it has been selected by the American Board of Surgery as one of three partners to provide a platform for its video-based assessment pilot program.

DiaSorin S.p.A. (“DiaSorin"; FTSE MIB: DIA) today announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (“Luminex"; NASDAQ: LMNX) for a price of USD 37.00 per share in an all-cash transaction.